Histone deacetylase as a new target for cancer chemotherapy.
about
Repression of promoter activity by CNOT2, a subunit of the transcription regulatory Ccr4-not complexHistone deacetylases (HDACs): characterization of the classical HDAC familyClinical and experimental applications of sodium phenylbutyrateInhibition of histone deacetylase 3 causes replication stress in cutaneous T cell lymphomaEpigenetic modulation with HDAC inhibitor CG200745 induces anti-proliferation in non-small cell lung cancer cellsHistone deacetylase inhibitors: a new mode for inhibition of cholesterol metabolism.Targeting the undruggable proteome: the small molecules of my dreams.Expression of the Breast Cancer Metastasis Suppressor 1 (BRMS1) maintains in vitro chemosensitivity of breast cancer cells.TPPP/p25 promotes tubulin acetylation by inhibiting histone deacetylase 6Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines.Activation of the growth-differentiation factor 11 gene by the histone deacetylase (HDAC) inhibitor trichostatin A and repression by HDAC3.Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1.Tax relieves transcriptional repression by promoting histone deacetylase 1 release from the human T-cell leukemia virus type 1 long terminal repeat.Histone deacetylase (HDAC) 1 controls the expression of beta defensin 1 in human lung epithelial cells.TdIF1 recognizes a specific DNA sequence through its Helix-Turn-Helix and AT-hook motifs to regulate gene transcription.Identification of an intrinsic determinant critical for maspin subcellular localization and function.Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.Peptides with anticancer use or potential.Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathwaysRomidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphomaHistone deacetylase inhibitors from Burkholderia thailandensis.Potential Prognostic Value of Histone Deacetylase 6 and Acetylated Heat-Shock Protein 90 in Early-Stage Breast CancerDifferential effects of histone deacetylase inhibitors in tumor and normal cells-what is the toxicological relevance?Applying whole-genome studies of epigenetic regulation to study human disease.Assays for pharmacodynamic analysis of histone deacetylase inhibitors.A histone deacetylase inhibitor, trichostatin A, enhances radiosensitivity by abrogating G2/M arrest in human carcinoma cellsHistone deacetylase inhibitors (HDACIs). Structure--activity relationships: history and new QSAR perspectives.Microbial natural products: molecular blueprints for antitumor drugs.Natural products as zinc-dependent histone deacetylase inhibitors.The discovery and development of romidepsin for the treatment of T-cell lymphoma.Medicinal significance of naturally occurring cyclotetrapeptides.Metabolism of arsenic trioxide in acute promyelocytic leukemia cells.An update on the use of benzoate, phenylacetate and phenylbutyrate ammonia scavengers for interrogating and modifying liver nitrogen metabolism and its implications in urea cycle disorders and liver disease.Selenium-containing histone deacetylase inhibitors for melanoma management.Chronic administration of valproic acid inhibits PC3 cell growth by suppressing tumor angiogenesis in vivo.Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells.Loss of oncostatin M receptor beta in metastatic melanoma cells.Regulation of the dynamics of hsp90 action on the glucocorticoid receptor by acetylation/deacetylation of the chaperone.Modulation of translation factor's gene expression by histone deacetylase inhibitors in breast cancer cells.Histone deacetylase inhibitor BL1521 induces a G1-phase arrest in neuroblastoma cells through altered expression of cell cycle proteins.
P2860
Q24304106-2D55E145-0CEE-47F3-ADFB-364E0D625DE0Q24535587-BCD77367-86B0-4A09-A2D3-1CDAAE9069AEQ24613511-E47661F7-286B-4BC4-95D5-10A32285BDCBQ28534761-B7DB409A-71A2-44E4-8689-25532B59B274Q28544442-CBDA087A-E0B5-480A-B90A-91D41896F662Q33380457-53B8B848-B10A-44C8-B466-005DCE941BABQ33627085-256F0766-C189-475F-9ACB-C9088A60E8B1Q33643007-B3BA5871-260A-4D78-A4D7-C3A786215FF1Q33885326-960AEB2E-08D6-4C55-9B48-5C742623028FQ34160419-4D096473-7FE1-4EC5-8968-AA57B5E0B82CQ34347410-127848FB-2BDD-4C7F-BAB7-64692A08BD6DQ34384609-25983B30-B03B-44EA-A9D8-C17EF87211D3Q34438734-48AAC636-B351-4A8E-B2C9-E6E1843B6862Q34490868-9C89294E-ADBB-40CC-BE56-989E749D1E04Q34846495-6D8356B8-8130-4719-A2E5-2286754BC418Q35053115-D452989D-F9C4-472B-BE64-1B3C7EE17C65Q35166852-4F5D2E57-1DF3-4FEE-A2CE-0C11B4D52C7EQ35167010-F8BD8272-4DB3-4C7B-BA09-D3ED019E155DQ35173372-5927367F-A0BB-438A-891A-0162B352C1B5Q35186682-F31B7868-6F10-46A3-A874-1B029643A57DQ35474016-1DA74B1C-0FF3-4204-9FAF-69E68E9D3D34Q36145714-EB8DE8D5-AEAC-4E58-96D4-4E7ACDA56794Q36179533-0EF839F6-2E3F-46D9-BA2C-505E234D939DQ36485572-6E18DA2F-29BC-42F9-9DA3-5A03EDE5896DQ36546255-63299CD2-6AE2-41DE-8F6F-CD08EF7D488CQ37446951-2D9E819B-8802-4CBC-ACD1-3F7926E96948Q37693855-2B297B3A-C15D-4818-BF15-6D0DEE60E74DQ38133765-31E1A5D0-7708-4E4A-98E2-6EA619E30FE4Q38315538-83C5A734-90A3-4B30-BFC5-D29959BCDE4FQ38713744-B331520E-D862-4EA1-9862-4CF9944472B1Q38853326-F7B0353D-668B-4630-BDAB-4E931B0A9CBAQ38995906-D483A25C-0935-4ED5-B7BA-3D9F27263F5BQ39012545-9FA7C55B-3BA3-4644-A7D0-26ED74F4A7AFQ39336516-A7997840-5A08-4DF9-84B4-EBA2CFD54FF8Q40087324-4697710A-7B5A-4E73-95CC-3DCC34AE1A95Q40197237-370ECE3E-6B38-4FF3-B4AF-F5786C5EF63DQ40243654-443F0AA1-1629-4522-9D8D-D0F455BFFC5FQ40387255-89052191-29E8-4588-B41C-7C8D33AA5752Q40432800-D77262B3-3EEA-4604-907C-284DCFED5D2EQ40454056-F3AC70BC-1824-4E94-9372-1B2C254CF624
P2860
Histone deacetylase as a new target for cancer chemotherapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Histone deacetylase as a new target for cancer chemotherapy.
@ast
Histone deacetylase as a new target for cancer chemotherapy.
@en
Histone deacetylase as a new target for cancer chemotherapy.
@nl
type
label
Histone deacetylase as a new target for cancer chemotherapy.
@ast
Histone deacetylase as a new target for cancer chemotherapy.
@en
Histone deacetylase as a new target for cancer chemotherapy.
@nl
prefLabel
Histone deacetylase as a new target for cancer chemotherapy.
@ast
Histone deacetylase as a new target for cancer chemotherapy.
@en
Histone deacetylase as a new target for cancer chemotherapy.
@nl
P2093
P356
P1476
Histone deacetylase as a new target for cancer chemotherapy
@en
P2093
M Nishiyama
S Horinouchi
P2888
P356
10.1007/S002800100300
P478
48 Suppl 1
P577
2001-08-01T00:00:00Z
P5875
P6179
1035768382